Braveheart Bio, Inc. Common Stock (BRVE)
Healthcare · Biotechnology · NASDAQ
Braveheart Bio, Inc. Common Stock (BRVE) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.12B.
| Market cap | $2.12B |
|---|
| Trailing P/E | — |
|---|
| FCF yield | — |
|---|
| Revenue growth (YoY) | — |
|---|
| EPS growth (YoY) | — |
|---|
| FCF/share growth (YoY) | — |
|---|
| Exchange | NASDAQ |
|---|
| Sector | Healthcare |
|---|
| Industry | Biotechnology |
|---|
See more: Healthcare stocks →